Skip to main content

Prime Movers Lab Fund I LP's Form 4 filing

Vaxxinity, Inc. (VAXX) · filed Jun 14, 2022

Accession no.
0001062993-22-014846
Filed
Jun 14, 2022, 7:08 PM ET
Trade date
Jun 10-13, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions. Open-market sales total $449.9K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Prime Movers Lab Fund I LPCIK 000175163110% Owner
Sloss DakinCIK 000187541110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 10, 2022Class A Common StockSSaleDisposed−6,687$2.80F7−$18,710.892,287,786Indirect
Jun 10, 2022Class A Common StockSSaleDisposed−2,512$2.80F7−$7,028.83859,345Indirect
Jun 10, 2022Class A Common StockSSaleDisposed−4,423$2.80F7−$12,3761,513,331Indirect
Jun 10, 2022Class A Common StockSSaleDisposed−28,378$2.80F7−$79,404.489,709,814Direct
Jun 13, 2022Class A Common StockSSaleDisposed−21,811$2.43F8−$52,911.32,265,975Indirect
Jun 13, 2022Class A Common StockSSaleDisposed−8,193$2.43F8−$19,875.4851,152Indirect
Jun 13, 2022Class A Common StockSSaleDisposed−14,427$2.43F8−$34,998.461,498,904Indirect
Jun 13, 2022Class A Common StockSSaleDisposed−92,569$2.43F8−$224,563.149,617,245Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F7

The price of $2.7981 per share represents a weighted average of purchase prices ranging from $2.40 to $3.15 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 4 transactions in Table I.

F8

The price of $2.4259 per share represents a weighted average of purchase prices ranging from $2.27 to $2.77 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 4 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)